Prime Behavior Testing Laboratories Inc. is a US-based company that serves to assist clients with the testing and evaluation of novel therapeutic agents and to identify products that may be suitable for clinical trials in an efficient and cost-effective manner. We specialize in cognition testing (Learning, Memory, and Attention) in rodent and Non-Human Primates (NHPs).
We test the efficacy of novel therapeutics for cognitive and psychiatric disorders. We also test drugs for abuse potential and abuse prevention.
Tests on rodent and Non-Human Primates are overseen by a full-time academic who runs the small animal core facility. We stay current due to ongoing scientific research studies in animal behavior.
PBTLI is unique from most other clinical research organizations - we provide specialized attention and cater our research specifically to your company's needs.
Interest in nicotinic acetylcholine receptor (nAChR) ligands as potential therapeutic agents for cognitive disorders began more than 30 years ago when it was first demonstrated that the tobacco alkaloid nicotine could improve cognitive function in nicotine-deprived smokers as well as nonsmokers.